Danaher controls more than 98% of Nobel Biocare and started squeeze out procedure

  21 januari 2015 - Nobel Biocare heeft een persbericht uitgegeven. Hieronder treft u de originele tekst aan.

Nobel Biocare Holding AG has been informed that Danaher Corporation today filed a petition with the Commercial Court of the Canton of Zurich for the annulation (Kraftloserklärung) of the remaining publicly held registered shares of Nobel Biocare against payment of the offer price that had been offered and paid by Danaher in its public tender offer for all publicly held registered shares of Nobel Biocare. 

Also, Nobel Biocare today filed petitions with SIX Swiss Exchange for the de-listing (Dekotierung) of the registered shares of Nobel Biocare from SIX Swiss Exchange and for exemptions from certain obligations under the Listing Rules of SIX Swiss Exchange, including in particular from certain publicity obligations.

Danaher's intentions with respect to these petitions had been disclosed and announced in its public tender offer documents.